$DOC

Healthpeak Properties earnings missed by $0.03, revenue topped estimates

Healthpeak Properties (DOC) reported Q3 EPS of $0.02, missing estimates by $0.03, but revenue of $813.69M exceeded expectations. The stock is down 7.68% over 3 months but up 11.06% year-over-year. InvestingPro rates its financial health as 'good performance.'

Original reporting
Published Nov 3, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DOC
Bearish
high confidence
Mentioned
$DOC
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DOCBearishMed
01

Why it matters

The earnings miss may lead to a near-term price decline, while the revenue beat offers a modest upside narrative.

02

Market read

First-report earnings miss for a mid-cap REIT, likely influencing short-term price action and sector sentiment.

03

What to watch

Recent lease renewals and occupancy rates were not discussed but could mitigate earnings concerns.

Relevance 7/10Novelty 6/10Timing: post-market release

Background

Healthpeak Properties (DOC) released its Q3 earnings, showing a slight EPS miss but revenue beat, with the stock closing at $19.48.

Company-level read

Ticker impact

$DOCBearishHigh confidence
Context

Q3 earnings missed EPS estimate by $0.03 and revenue topped estimates, providing fresh earnings data.

Expected impact

likely downward pressure as investors price in the EPS miss

Evidence & confidence

The miss of $0.03 versus consensus is material for a REIT and the report is the first disclosure of these numbers.

Market effects

Potential drag on the REIT sector as earnings miss may raise concerns about property income trends.

US real estate market may see modest repricing following the miss.

Limited global impact; primarily affects US REIT investors.

Counterpoint

The revenue beat could support a view that the miss is a short-term blip and the stock may rebound.

Key entities

  • Healthpeak Properties

    US-listed REIT focused on healthcare real estate.

Related articles

$DOCHigh

Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER, November 2, 2026 - Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery

$CCIMed

Better High-Yield Dividend Stock: Crown Castle vs. Healthpeak

Crown Castle (CCI) and Healthpeak Properties (PEAK) both raised 2026 outlooks in Q2. CCI yields 5.4% with a 93% AFFO payout ratio for 2026, while PEAK yields 6.7% with a 78% ratio. CCI trades at 16x forward AFFO, PEAK at 12x. Both have cut dividends previously. CCI's Q2 AFFO rose to $1.13/share, with full-year outlook at $4.53-$4.65.

$DOCMedAI 8/10

Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

$DOCMed

Healthpeak Properties Q2 Earnings Call Highlights

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

$DOCMed

Is Wall Street Bullish or Bearish on Healthpeak Properties Stock?

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.